Skip to main content
SpringerLink
Log in

Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The optimal therapeutic regimen for Helicobacter pylori (H. pylori) infection has not been established in end-stage renal disease (ESRD) patients receiving hemodialysis. We investigated the efficacy and safety of a 7-day omeprazole-based triple therapy with low doses of amoxicillin and clarithromycin (OAC) for eradication of H. pylori infection in ESRD patients receiving hemodialysis.

Methods

Thirty-three hemodialysis patients and 55 patients with normal renal function underwent upper gastrointestinal endoscopy. For eradication of H. pylori infection, a 7-day triple therapy with low-dose OAC (omeprazole 40 mg daily, amoxicillin 500 mg daily, and clarithromycin 500 mg daily) regimen was used. Four weeks after the completion of the OAC regimen, the success of the H. pylori eradication therapy was determined by histological examination and rapid urease test.

Results

The prevalence of H. pylori infection was 36.4% in hemodialysis patients and 65.5% in non-uremic patients (p = 0.0150). The mean duration of hemodialysis in H. pylori-positive and -negative patients was 56.8 ± 26.9 versus 66.4 ± 26.1 months, respectively (p = 0.3196). Eradication was successful in 83.4% of hemodialysis patients and 81.0% of non-uremic patients (p = 1.000). All patients completed the eradication therapy without any serious adverse effects.

Conclusion

A 7-day triple therapy with a low-dose OAC regimen was effective and safe for eradication of H. pylori infection in hemodialysis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75:96–103.

    Article  PubMed  Google Scholar 

  2. Al-Mueilo SH. Gastroduodenal lesions and Helicobacter pylori infection in hemodialysis patients. Saudi Med J. 2004;25:1010–4.

    PubMed  Google Scholar 

  3. Moustafa FE, Khalil A, Abdel Wahab M, Sobh MA. Helicobacter pylori and uremic gastritis: a histopathologic study and a correlation with endoscopic and bacteriologic findings. Am J Nephrol. 1997;17:165–71.

    Article  CAS  PubMed  Google Scholar 

  4. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut. 2007;56:772–81.

    Article  CAS  PubMed  Google Scholar 

  5. Mak SK, Loo CK, Wong AM, Wong PN, Lo KY, Tong GM, et al. Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure. Am J Kidney Dis. 2002;40:576–81.

    Article  CAS  PubMed  Google Scholar 

  6. Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808–25.

    Article  CAS  PubMed  Google Scholar 

  7. Tamura H, Tokushima H, Murakawa M, Matsumura O, Itoyama S, Sekine S, et al. Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment. Am J Kidney Dis. 1997;29:86–90.

    Article  CAS  PubMed  Google Scholar 

  8. Mak SK, Loo CK, Wong PN, Lo KY, Tong GM, Lam EK, et al. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure. Singapore Med J. 2003;44:74–8.

    CAS  PubMed  Google Scholar 

  9. Wang YL, Sheu BS, Huang JJ, Yang HB. Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients. Am J Kidney Dis. 2001;38:98–103.

    Article  CAS  PubMed  Google Scholar 

  10. Tsukada K, Miyazaki T, Katoh H, Masuda N, Ojima H, Fukai Y, et al. Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in hemodialysis patients. Scand J Gastroenterol. 2002;37:1265–8.

    Article  CAS  PubMed  Google Scholar 

  11. Itatsu T, Miwa H, Nagahara A, Kubota M, Miyazaki A, Sato N, et al. Eradication of Helicobacter pylori in hemodialysis patients. Ren Fail. 2007;29:97–102.

    Article  CAS  PubMed  Google Scholar 

  12. Veldhuyzen van Zanten S, Chiba N, Barkun A, Fallone C, Farley A, Cockeram A, et al. A randomized trial comparing 7-day ranitidine bismuth citrate and clarithromycin dual therapy to 7-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Can J Gastroenterol. 2003;17:533–8.

    PubMed  Google Scholar 

  13. Arancibia A, Drouguett MT, Fuentes G, González G, González C, Thambo S, et al. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. Int J Clin Pharmacol Ther Toxicol. 1982;20:447–53.

    CAS  PubMed  Google Scholar 

  14. Fraschini F, Scaglione F, Demartini G. Clarithromycin clinical pharmacokinetics. Clin Pharmacokinet. 1993;25:189–204.

    Article  CAS  PubMed  Google Scholar 

  15. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002;31:128–39.

    Article  PubMed  Google Scholar 

  16. Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med. 2007;147:553–62.

    PubMed  Google Scholar 

  17. Klotz U. Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet. 2000;38:243–70.

    Article  CAS  PubMed  Google Scholar 

  18. Humbert G, Spyker DA, Fillastre JP, Leroy A. Pharmacokinetics of amoxicillin: dosage nomogram for patients with impaired renal function. Antimicrob Agents Chemother. 1979;15:28–33.

    CAS  PubMed  Google Scholar 

  19. Aydemir S, Boyacioglu S, Gur G, Demirbilek M, Can FK, Korkmaz M, et al. Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. World J Gastroenterol. 2005;14:842–5.

    Google Scholar 

  20. Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol. 2002;26:216–9.

    PubMed  Google Scholar 

  21. Harris AW, Misiewicz JJ. Treating Helicobacter pylori—the best is yet to come? Gut. 1996;39:781–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This paper was supported by the Second-Phase of BK-21 Project in 2010 of Konkuk University.

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Internal Medicine, Konkuk University Hospital, 4-12 Hwayang-dong, Gwangjin-gu, Seoul, 143-729, Korea

    Won-Chul Chang, Young-Il Jo, Jung-Hwan Park & Jong-Ho Lee

  2. Division of Gastroenterology, Department of Internal Medicine, Konkuk University Hospital, Seoul, Korea

    Hyung-Seok Park & Choon-Jo Jin

  3. Institute of Biomedical Science and Technology of Konkuk University, Seoul, Korea

    Joon Jegal

  4. BK-21, Konkuk University School of Medicine, Seoul, Korea

    Young-Il Jo

Authors
  1. Won-Chul Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young-Il Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hyung-Seok Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joon Jegal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung-Hwan Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jong-Ho Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Choon-Jo Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young-Il Jo.

About this article

Cite this article

Chang, WC., Jo, YI., Park, HS. et al. Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients. Clin Exp Nephrol 14, 469–473 (2010). https://doi.org/10.1007/s10157-010-0319-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0319-7

Keywords

Search

Navigation